| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.3M | +52.5% |
| SG&A Expense | $2.7M | +2.1% |
| Operating Income | -$4.0M | -10.5% |
| Interest Expense | $629K | +37.6% |
| Pre-tax Income | -$5.5M | -20.0% |
| Net Income | -$5.5M | -20.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $93K | -62.0% |
| Current Assets | $314K | -30.1% |
| Total Assets | $314K | -30.6% |
| Current Liabilities | $10.1M | +20.7% |
| Stockholders' Equity | -$9.8M | -23.6% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.4M | -21.8% |
| Financing Cash Flow | $3.2M | +7.8% |